ZIM Laboratories
ZIM Laboratories Share Price Chart
ZIM Laboratories last traded at ₹153.00 (2026-10-13). Over the past month the stock moved +10.2%, three months the stock moved +50.0%, year the stock moved +102.2%. Its closing range over 52 weeks is ₹64.09 – ₹153.10, with the latest close 0.1% below the high.
Closing prices up to 2026-10-13.
About ZIM Laboratories
Incorporated in 1989, Zim Laboratories Ltd manufactures formulation drugs and pre formulation ingredients in India and markets and sells these within and out side India[1]
Business Overview:[1] ZLL is a EU-GMP, WHOGMP, NSF/ANSI 455-2 certified research-driven pharmaceutical company that develops, manufactures and supplies generic products in the oral solid dosage forms, both as pre-formulation intermediates ad finished formulations for certain key therapeutic segments. It offers both pharmaceutical and nutraceutical products. Company has an in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), ZIM Laboratories reported sales of ₹94.18 crore (+31.2%) and net profit of ₹-4.02 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 94.18 | 2.45 | 2.60 | -4.02 | -0.75 |
| Mar 2026 | 105.27 | 7.19 | 6.83 | 3.74 | 0.70 |
| Dec 2025 | 108.66 | 12.81 | 11.79 | 4.40 | 0.90 |
| Sep 2025 | 88.71 | 5.76 | 6.49 | -0.42 | -0.09 |
| Jun 2025 | 71.76 | 4.25 | 5.92 | -1.87 | -0.38 |
| Mar 2025 | 108.73 | 14.60 | 13.43 | 4.88 | 1.00 |
| Dec 2024 | 96.33 | 11.56 | 12.00 | 4.00 | 0.82 |
| Sep 2024 | 92.14 | 9.53 | 10.34 | 2.38 | 0.49 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +7.4% | +0.0% | -7.7% | -12.3% | -3.7% | +12.8% | -3.2% | +31.2% |
| Operating profit growth | +2.1% | +0.2% | -6.7% | -47.1% | -39.6% | +10.8% | -50.8% | -42.4% |
| Net profit growth | -42.7% | -16.3% | -39.7% | -307.8% | -117.6% | +10.0% | -23.4% | – |
| EPS growth | -42.4% | -16.3% | -39.8% | -311.1% | -118.4% | +9.8% | -30.0% | – |
| OPM % | 10.3% | 12.0% | 13.4% | 5.9% | 6.5% | 11.8% | 6.8% | 2.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), ZIM Laboratories reported sales of ₹374.00 crore (-1.3%) and net profit of ₹6.00 crore (-50.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 374.00 | 30.00 | 8.00 | 6.00 | 1.09 |
| Mar 2025 | 379.00 | 44.00 | 12.00 | 12.00 | 2.50 |
| Mar 2024 | 367.00 | 41.00 | 11.00 | 17.00 | 3.54 |
| Mar 2023 | 399.00 | 52.00 | 13.00 | 24.00 | 5.01 |
| Mar 2022 | 333.00 | 41.00 | 12.00 | 15.00 | 2.99 |
| Mar 2021 | 307.00 | 40.00 | 13.00 | 7.00 | 1.50 |
| Mar 2020 | 278.00 | 23.00 | 8.00 | 3.00 | 0.68 |
| Mar 2019 | 335.00 | 42.00 | 13.00 | 15.00 | 3.17 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +22.7% | -17.0% | +10.4% | +8.5% | +19.8% | -8.0% | +3.3% | -1.3% |
| Operating profit growth | +20.0% | -45.2% | +73.9% | +2.5% | +26.8% | -21.2% | +7.3% | -31.8% |
| Net profit growth | -21.1% | -80.0% | +133.3% | +114.3% | +60.0% | -29.2% | -29.4% | -50.0% |
| EPS growth | – | -78.5% | +120.6% | +99.3% | +67.6% | -29.3% | -29.4% | -56.4% |
| OPM % | 13.0% | 8.0% | 13.0% | 12.0% | 13.0% | 11.0% | 12.0% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for ZIM Laboratories.
Get Free AI Stock Analysis FREE →Latest News
-
Zim Laboratories incorporates wholly owned subsidiary in Republic of Chile
-
Zim Laboratories, Transworld Shipping Lines and ACME Solar Holdings to see some action today
-
ZIM Laboratories secures marketing authorization for ‘Dabigatran Etexilate’ in Italy
-
Sambhv Steel Tubes, ITC Hotels and ZIM Laboratories to see some action today
-
Zim Laboratories reports Profit after tax of Rs 32.81 Mln, in the March 2026 quarter
-
Zim Laboratories reports Profit after tax of Rs 32.81 Mln, in the March 2026 quarter
-
ZIM Laboratories Completes EU GMP Inspection by German and Portuguese Regulatory Authorities - scanx.trade
-
ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS
-
ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS
-
ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS
Frequently Asked Questions
What is ZIM Laboratories's current stock price?
ZIM Laboratories shares were last quoted at ₹153.00 (+1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of ZIM Laboratories?
ZIM Laboratories has a price-to-earnings (P/E) ratio of 200.87 and a price-to-book (P/B) ratio of 2.55. The industry P/E is 53.33.
What is the 52-week high and low of ZIM Laboratories?
The 52-week high of ZIM Laboratories is ₹144.85 and the 52-week low is ₹59.72.
What is the market cap of ZIM Laboratories?
The market capitalisation of ZIM Laboratories is about ₹743.71 crore.
How did ZIM Laboratories perform in its latest quarterly results?
In the latest quarter (Jun 2026), ZIM Laboratories reported sales of ₹94.18 crore (+31.2%) and net profit of ₹-4.02 crore, compared with the same quarter last year.
Is ZIM Laboratories a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, ZIM Laboratories has a 3-year ROE of 5.00%, 3-year profit growth of -44.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in ZIM Laboratories?
Promoters hold about 30.36% of ZIM Laboratories.
Which sector does ZIM Laboratories belong to?
ZIM Laboratories belongs to the Pharmaceuticals & Drugs sector.